Base de dados : HANSEN
Pesquisa : INFECCOES POR HIV/QUIMIOTER [Descritor de assunto]
Referências encontradas : 6 [refinar]
Mostrando: 1 .. 6   no formato [Detalhado]

página 1 de 1

  1 / 6 HANSEN  
              next record last record
seleciona
para imprimir
Id:18947
Autor:Dredge, Keith; Marriott, J. Blake; Dalgleish, Angus G
Título:Immunological effects of thalidomide and its chemical and functional analogs
..-
Fonte:s.l; s.n; 2002. 13 p. ilus, tab.
Resumo:Thalidomide has recently shown considerable promise in the treatment of a number of conditions, such as leprosy and cancer. Its effectiveness in the clinic has been ascribed to wide-ranging properties, including anti-TNF-alpha, T-cell costimulatory and antiangiogenic activity. Novel compounds with improved immunomodulatory activity and side effect profiles are also being evaluated. These include selective cytokine inhibitory drugs (SelCIDs), with greatly improved TNF-alpha inhibitory activity, and immunomodulatory drugs (IMiDs) that are structural analogs of thalidomide, with improved properties. A third group recently identified within the SelCID group, with phosphodiesterase type 4-independent activity, is in the process of being characterized in laboratory studies. This review describes the emerging immunological properties of thalidomide, from a historical context to present-day clinical applications, most notably in multiple myeloma but also in other cancers, inflammatory disease, and HIV. We also describe the laboratory studies that have led to the characterization and development of SelCIDs and IMiDs into potentially clinically relevant drugs. Early trial data suggest that these novel immunomodulatory compounds may supercede thalidomide to become established therapies, particularly in certain cancers. Further evidence is required, however, to correlate the clinical efficacy of these compounds with their known immunomodulatory, antiangiogenic, and antitumor properties. (AU).
Descritores:TALIDOMIDA/analog
TALIDOMIDA/imunol
TALIDOMIDA/farmacol
SISTEMA IMUNE/ef drogas
NEOPLASIAS/quimioter
NEOPLASIAS/imunol
INFECCOES POR HIV/quimioter
INFECCOES POR HIV/imunol
ADJUVANTES IMUNOLOGICOS/farmacol
INIBIDORES DE ANGIOGÊNESE/imunol
INIBIDORES DE ANGIOGÊNESE/farmacol
ANTIVIRAIS/imunol
ANTIVIRAIS/farmacol
Limites:HUMANO
Meio Eletrônico: - .
Localização:BR191.1; 04731/s


  2 / 6 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:18582
Autor:Lawn, S. D; Wood, C; Lockwood, D. N
Título:Borderline tuberculoid leprosy: an immune reconstitution phenomenon in a human immunodeficiency virus-infected person
..-
Fonte:s.l; s.n; 2003. 2 p. ilus.
Resumo:Two months after starting highly active antiretroviral treatment (HAART), an individual with human immunodeficiency virus type 1 (HIV-1) infection and profound CD4+ T lymphocytopenia developed several erythematous plaques on his face, which were due to borderline tuberculoid leprosy with reversal reaction. The temporal association between the development of these lesions and changes in blood CD4+ lymphocyte count and plasma HIV-1 load observed during HAART strongly suggests that the presentation of leprosy resulted from immune reconstitution. (AU).
Descritores:INFECCOES OPORTUNISTAS RELACIONADAS COM A AIDS/imunol
AGENTES ANTI-HIV/uso terap
TERAPIA ANTI-RETROVIRAL DE ALTA ATIVIDADE/ef adv
CONTAGEM DE LINFOCITO CD4
INFECCOES POR HIV/compl
INFECCOES POR HIV/quimioter
INFECCOES POR HIV/imunol
HANSENIASE TUBERCULOIDE/etiol
HANSENIASE TUBERCULOIDE/imunol
IMUNIDADE/ef drogas
Limites:RELATO DE CASO
HUMANO
MASCULINO
ADULTO
Meio Eletrônico: - .
Localização:BR191.1; 09026/s


  3 / 6 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:18350
Autor:Lawn, S. D; Wood, C; Lockwood, D. N
Título:Borderline tuberculoid leprosy: an immune reconstitution phenomenon in a human immunodeficiency virus-infected person
..-
Fonte:s.l; s.n; Jan. 2003. 3 p. ilus.
Resumo:Two months after starting highly active antiretroviral treatment (HAART), an individual with human immunodeficiency virus type 1 (HIV-1) infection and profound CD4+ T lymphocytopenia developed several erythematous plaques on his face, which were due to borderline tuberculoid leprosy with reversal reaction. The temporal association between the development of these lesions and changes in blood CD4+ lymphocyte count and plasma HIV-1 load observed during HAART strongly suggests that the presentation of leprosy resulted from immune reconstitution. (AU).
Descritores:HANSENIASE TUBERCULOIDE/etiol
HANSENIASE TUBERCULOIDE/imunol
INFECCOES POR HIV/compl
INFECCOES POR HIV/quimioter
INFECCOES POR HIV/imunol
CONTAGEM DE LINFOCITO CD4
INFECCOES OPORTUNISTAS RELACIONADAS COM A AIDS/imunol
AGENTES ANTI-HIV/uso terap
TERAPIA ANTI-RETROVIRAL DE ALTA ATIVIDADE/ef adv
IMUNIDADE/ef drogas
Limites:RELATO DE CASO
HUMANO
MASCULINO
ADULTO
Localização:BR191.1; 09166/s


  4 / 6 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:15324
Autor:Miller, Marilyn T; Stromland, Kerstin
Título:Teratogen update: thalidomide: a review, with a focus on ocular findings and new potential uses
..-
Fonte:s.l; s.n; 1999. 16 p. ilus, tab.
Descritores:ANORMALIDADES DO OLHO
ANORMALIDADES DO OLHO
INFECÇOES POR HIV
HISTORIA DA MEDICINA DO SÉCULO 15
HISTORIA DA MEDICINA DO SÉCULO 20
RECÉM-NASCIDO
HANSENIASE
TROCA MATERNO-FETAL
NEOVASCULARIZAÇAO PATOLOGICA
GRAVIDEZ
SUÉCIA
TERATOGENIOS
TERATOGENIOS
TALIDOMIDA
TALIDOMIDA
Deformidades Congênitas dos Membros/CI/EP/HI
Localização:BR191.1; 07245/s


  5 / 6 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:14981
Autor:Calabrese, Leonard; Fleischer, Alan B
Título:Thalidomide: current and potential clinical applications
..-
Fonte:s.l; s.n; 2000. 9 p. tab.
Descritores:HANSENIASE LEPROMATOSA
LEPROSTATICOS
LEPROSTATICOS
LEPROSTATICOS
ARTRITE REUMATOIDE
SINDROME DE BEHCET
AGENTES DERMATOLOGICOS
AGENTES DERMATOLOGICOS
AGENTES DERMATOLOGICOS
ECTROMELIA
ERITEMA NODOSO
DOENÇA ENXERTO-HOSPEDEIRO
INFECÇOES POR HIV
IMUNOSSUPRESSORES
IMUNOSSUPRESSORES
IMUNOSSUPRESSORES
LUPUS ERITEMATOSO CUTANEO
NEOPLASIAS
DOENÇAS DO SISTEMA NERVOSO PERIFÉRICO
ESTOMATITE AFTOSA
TERATOGENIOS
TALIDOMIDA
TALIDOMIDA
TALIDOMIDA
Localização:BR191.1; 07430/s


  6 / 6 HANSEN  
              first record previous record
seleciona
para imprimir
Id:13632
Autor:Giedlin, Martin A; Zimmerman, Robert J
Título:The use of recombinant human interleukin-2 in treating infectious diseases
..-
Fonte:s.l; s.n; 1993. 5 p. .
Descritores:INFECÇOES POR HIV
INTERLEUCINA-2
HANSENIASE
PROTEINAS RECOMBINANTES
TUBERCULOSE
Limites:ANIMAL
Localização:BR191.1; 06556/s



página 1 de 1
   


Refinar a pesquisa
  Base de dados : HANSEN Formulário avançado   
Pesquisar por : Formulário livre   

    Pesquisar no campo  
1  
2
3
 
           



Search engine: iAH v2.6.1 powered by WWWISIS

BIREME/PAHO/WHO - Latin American and Caribbean Center on Health Sciences Information